Whole cell-ELISA to measure the γH2AX response of six aneugens and eight DNA-damaging chemicals

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 700, Issue 1-2, 2010, Pages 71-79

  Matsuzaki, Kaori ^a   Harada, Asako ^a   Takeiri, Akira ^a   Tanaka, Kenji ^a   Mishima, Masayuki ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

H2AX; Aneugen; ELISA; Genotoxicity

Indexed keywords

ANEUGEN; ANTIBODY; BIOLOGICAL MARKER; CH 3310395; CISPLATIN; DEMECOLCINE; DOUBLE STRANDED DNA; ETHYLNITRONITROSOGUANIDINE; ETOPOSIDE; FLUOROURACIL; GRISEOFULVIN; HISTONE H2AX; HISTONE H2AX GAMMA; IRINOTECAN; MESYLIC ACID METHYL ESTER; METHOTREXATE; MITOMYCIN C; PACLITAXEL; TANESPIMYCIN; UNCLASSIFIED DRUG; VINCRISTINE;

AMES TEST; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN CHL; CELL STRAIN V 79; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENOTOXICITY; IMMUNOFLUORESCENCE TEST; MICRONUCLEUS TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; WHOLE CELL;

ANEUGENS; ANIMALS; CELL LINE; DNA DAMAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTONES; HUMANS; MUTAGENS;

EID: 77953915626     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.05.009     Document Type: Article

References (49)

1. Jeggo P.A., Löbrich M. DNA double-strand breaks: their cellular and clinical impact?. Oncogene 2007, 26:7717-7719.
2. Bonner W.M., Redon C.E., Dickey J.S., Nakamura A.J., Sedelnikova O.A., Solier S., Pommier Y. γH2AX and cancer. Nat. Rev. Cancer 2008, 8:957-967.
3. Kinner A., Wu W., Staudt C., Iliakis G. γH2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008, 36:5678-5694.
4. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 1999, 146:905-915.
5. Rothkamm K., Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5057-5062.
6. Pascucci B., Russo M.T., Crescenzi M., Bignami M., Dogliotti E. The accumulation of MMS-induced single strand breaks in G1 phase is recombinogenic in DNA polymerase β defective mammalian cells. Nucleic Acids Res. 2005, 33:280-288.
7. Hanasoge S., Ljungman M. H2AX phosphorylation after UV irradiation is triggered by DNA repair intermediates and is mediated by the ATR kinase. Carcinogenesis 2007, 28:2298-2304.
8. Niedernhofer L.J., Odijk H., Budzowska M., van Drunen E., Maas A., Theil A.F., de Wit J., Jaspers N.G., Beverloo H.B., Hoeijmakers J.H.J., Kanaar R. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol. Cell Biol. 2004, 24:5776-5787.
9. Furuta T., Takemura H., Liao Z.Y., Aune G.J., Redon C., Sedelnikova O.A., Pilch D.R., Rogakou E.P., Celeste A., Chen H.T., Nussenzweig A., Aladjem M.I., Bonner W.M., Pommier Y. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem. 2003, 278:20303-20312.
10. Takahashi A., Ohnishi T. Does γH2AX foci formation depend on the presence of DNA double strand breaks?. Cancer Lett. 2005, 229:171-179.
11. Zhou C., Li Z., Diao H., Yu Y., Zhu W., Dai Y., Chen F.F., Yang J. DNA damage evaluated by γH2AX foci formation by a selective group of chemical/physical stressors. Mutat. Res. 2006, 604:8-18.
12. Mishima M., Tanaka K., Takeiri A., Harada A., Kubo C., Sone S., Nishimura Y., Tachibana Y., Okazaki M. Two structurally distinct inhibitors of glycogen synthase kinase 3 induced centromere positive micronuclei in human lymphoblastoid TK6 cells. Mutat. Res. 2008, 643:29-35.
13. Niikura Y., Ohta S., Vandenbeldt K.J., Abdulle R., McEwen B.F., Kitagawa K. 17-AAG, an Hsp90 inhibitor, causes kinetochore defects: a novel mechanism by which 17-AAG inhibits cell proliferation. Oncogene 2006, 25:4133-4146.
14. Kirkland D, Aardema M., Henderson L., Müller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res. 2005, 584:1-256.
15. Ishidate M., Harnois M.C., Sofuni T. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat. Res. 1988, 195:151-213.
16. Matsuoka A., Yamazaki N., Suzuki T., Hayashi M., Sofuni T. Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res. 1993, 272:223-236.
17. Matsushima T., Hayashi M., Matsuoka A., Ishidate M., Miura K.F., Shimizu H., Suzuki Y., Morimoto K., Ogura H., Mure K., Koshi K., Sofuni T. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis 1999, 14:569-580.
18. National toxicology program, NTP website at http://ntp-server.niehs.nih.gov/.
19. Rodilla V., Pellicer J.A., Pertusa J., Mothersill C. Induction of micronucleated and binucleate cells in Chinese hamster ovary (CHO) cells by cis-diamminedichloroplatinum (II): a morphological and morphometric study. Mutat. Res. 1990, 241:115-124.
20. Shimada H., Hattori C., Sato T., Ebine Y. Mutagenicity studies of CPT-11, a new anticancer drug. Clin. Rep. 1990, 24:7357-7366. Japanese.
21. Kopjar N, Zeljezić D., Vrdoljak A.L., Radić B., Ramić S., Milić M., Gamulin M., Pavlica V., Fucić A. Irinotecan toxicity to human blood cells in vitro: relationship between various biomarkers. Basic Clin. Pharmacol. Toxicol. 2007, 100:403-413.
22. Nakanomyo H., Hiraoka M., Shiraya M. Mutagenicity tests of etoposide and teniposide. J. Toxicol. Sci. 1986, 11(Suppl. 1):301-310.
23. Gupta R.S., Bromke A., Bryant D.W., Gupta R., Singh B., McCalla D.R. Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems. Mutagenesis 1987, 2:179-186.
24. Suzuki H, Nakane S. Differential induction of chromosomal aberrations by topoisomerase inhibitors in cultured Chinese hamster cells. Biol. Pharm. Bull. 1994, 17:222-226.
25. Hermine T., Jones N.J., Parry J.M. Comparative induction of micronuclei in repair-deficient and -proficient Chinese hamster cell lines following clastogen or aneugen exposures. Mutat. Res. 1997, 392:151-163.
26. Keshava C., Keshava N., Whong W.Z., Nath J., Ong T.M. Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells. Mutat. Res. 1998, 397:221-228.
27. Kirsch-Volders M., Parry E.M. Genetic toxicology of mitotic spindle inhibitors used as anticancer drugs. Mutat. Res. 1996, 355:103-128.
28. Sakamoto Y., Fujikawa K., Nagayabu O., Yamamoto K.S., Samejima K. Triple short-term tests with bacteria and drosophila for assessment of mutagenicity of antineoplastics. Takeda Kenkyusho Ho 1985, 44:96-116.
29. Ma H., Wang Z., Liao M. Genetic toxicity of taxol. Zhongguo Yaolixue Yu Dulixue Zazhi 1996, 10:173-177.
30. Choy W.N., Kersey K., Zhong Z., Eng S., Lin L.J., Roper J., Bokelmen D., Sherrill M., Timmermans P., Johnson R. Preclinical safety profile of tanespimycin (KOS-953), a heat shock protein 90 (HSP90) inhibitor. Poster Presented at the 98th Annual Meeting of the American Association for Cancer Research 2007.
31. Begg A.C., Mooren E. Rapid fluorescence-based assay for radiosensitivity and chemosensitivity testing in mammalian cells in vitro. Cancer Res. 1989, 49:565-569.
32. Lasko T.A., Bhagwat J.G., Zou K.H., Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J. Biomed. Inform. 2005, 38:404-415.
33. Hamasaki K., Imai K., Nakachi K., Takahashi N., Kodama Y., Kusunoki Y. Short-term culture and γH2AX flow cytometry determine differences in individual radiosensitivity in human peripheral T lymphocytes. Environ. Mol. Mutagen. 2007, 48:38-47.
34. Rogakou E.P., Nieves-Neira W., Boon C., Pommier Y., Bonner W.M. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J. Biol. Chem. 2000, 275:9390-9395.
35. Solier S., Pommier Y. The apoptotic ring: a novel entity with phosphorylated histones H2AX and H2B and activated DNA damage response kinases. Cell Cycle 2009, 8:1853-1859.
36. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
37. Huang X., Halicka H.D., Traganos F., Tanaka T., Kurose A., Darzynkiewicz Z. Cytometric assessment of DNA damage in relation to cell cycle phase and apoptosis. Cell Prolif. 2005, 38:223-243.
38. Yoshioka A., Tanaka S., Hiraoka O., Koyama Y., Hirota Y., Ayusawa D., Seno T., Garrett C., Wataya Y. Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J. Biol. Chem. 1987, 262:8235-8241.
39. Oka H., Ikeda K., Yoshimura H., Ohuchida A., Honma M. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines. Mutat. Res. 2006, 606:52-60.
40. Lorge E., Thybaud V., Aardema M.J., Oliver J., Wakata A., Lorenzon G., Marzin D. SFTG, international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. Mutat. Res. 2006, 607:13-36.
41. Underhill T.M., Flintoff W.F. Complementation of a methotrexate uptake defect in Chinese hamster ovary cells by DNA-mediated gene transfer. Mol. Cell Biol. 1989, 9:1754-1758.
42. Galloway S.M., Deasy D.A., Bean C.L., Kraynak A.R., Armstrong M.J., Bradley M.O. Effects of high osmotic strength on chromosome aberrations, sister-chromatid exchanges and DNA strand breaks, and the relation to toxicity. Mutat. Res. 1987, 189:15-25.
43. Watters G.P., Smart D.J., Harvey J.S., Austin C.A. H2AX phosphorylation as a genotoxicity endpoint. Mutat. Res. 2009, 679:50-58.
44. Aardema M.J., Albertini S., Arni P., Henderson L.M., Kirsch-Volders M., Mackay J.M., Sarrif A.M., Stringer D.A., Taalman R.D.F. Aneuploidy: a report of an ECETOC task force. Mutat. Res. 1998, 410:3-79.
45. Elhajouji A., Van Hummelen P., Kirsch-Volders M. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen. 1995, 26:292-304.
46. Wang L., Eastmond D.A. Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187. Environ. Mol. Mutagen. 2002, 39:348-356.
47. Sonoda E., Hochegger H., Saberi A., Taniguchi Y., Takeda S. Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair 2006, 5:1021-1029.
48. Iliakis G., Wang H., Perrault A.R., Boecker W., Rosidi B., Windhofer F., Wu W., Guan J., Terzoudi G., Pantelias G. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet. Genome Res. 2004, 104:14-20.
49. Escargueil A.E., Soares D.G., Salvador M., Larsen A.K., Henriques J.A.P. What histone code for DNA repair?. Mutat. Res. 2008, 658:259-270.